Express Scripts Holding Rating Increased to Buy at Jefferson Research (ESRX)
Express Scripts Holding (NASDAQ:ESRX) was upgraded by Jefferson Research from a “hold” rating to a “buy” rating in a research note issued on Friday, Analyst Ratings Net reports.
Other equities research analysts have also recently issued reports about the stock. Analysts at Credit Suisse raised their price target on shares of Express Scripts Holding from $75.00 to $83.00 in a research note on Friday, January 17th. Separately, analysts at Mizuho raised their price target on shares of Express Scripts Holding from $74.00 to $86.00 in a research note on Friday, January 17th. They now have a “buy” rating on the stock. Finally, analysts at Goldman Sachs raised their price target on shares of Express Scripts Holding from $75.00 to $77.00 in a research note on Tuesday, December 17th. Six equities research analysts have rated the stock with a hold rating and nineteen have issued a buy rating to the company’s stock. Express Scripts Holding presently has an average rating of “Buy” and a consensus target price of $72.75.
Express Scripts Holding (NASDAQ:ESRX) traded down 0.47% on Friday, hitting $76.24. 1,399,326 shares of the company’s stock traded hands. Express Scripts Holding has a 52 week low of $54.48 and a 52 week high of $76.69. The stock has a 50-day moving average of $73.00 and a 200-day moving average of $66.78. The company has a market cap of $61.435 billion and a P/E ratio of 34.44.
Express Scripts, Inc is a pharmacy benefit management (NASDAQ:ESRX) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.